Literature DB >> 3629642

Cerebellar infarction: natural history, prognosis, and pathology.

R A Macdonell, R M Kalnins, G A Donnan.   

Abstract

Using clinical and computed tomography (CT) criteria, an analysis of 2,000 consecutive stroke unit patients from 1977 to 1984 revealed 30 patients with cerebellar infarction. The case fatality rate was 23%, higher than for any other location of brain infarction studied over the same period. Death was most often due to concomitant brainstem infarction. Obstructive hydrocephalus occurred in 4 patients (13%), and in 2 cases diagnosis, facilitated by urgent CT scanning, allowed early surgical intervention that was life saving. Patients who survived the acute phase were followed for an average of 21 months, and over that time 22% sustained further brainstem infarction, representing a 13% stroke rate per year. Over the latter 3 years of the clinical study, an autopsy survey revealed 11 cases of cerebellar infarction that had been clinically unrecognized. None of these died as a direct result of their infarction. Mechanisms of infarction inferred from autopsy included in situ thrombosis, embolism, watershed, and lacunar infarction, with in situ thrombosis being the most common. We conclude that the case fatality rate of cerebellar infarction is greater than of any other form of brain infarction, but it may be reduced by prompt recognition of those patients who will benefit from surgical decompression. In survivors, a high risk of subsequent hindbrain stroke exists. More attention needs to be paid to this entity in terms of early diagnosis and prevention of subsequent stroke.

Entities:  

Mesh:

Year:  1987        PMID: 3629642     DOI: 10.1161/01.str.18.5.849

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  30 in total

1.  Cerebellar strokes: a clinical outcome review of 79 cases.

Authors:  Z X Ng; W R Yang; E Seet; K M Koh; K J Teo; S W Low; N Chou; T T Yeo; N Venketasubramanian
Journal:  Singapore Med J       Date:  2015-03       Impact factor: 1.858

2.  Association of endothelial lipase genetic polymorphism with lacunar infarction in a Chinese population.

Authors:  Jian Wang; Bo Zheng; Qing-Song Wang; Jun Wang; Sai-Yu Cheng; Jie Li
Journal:  Int J Clin Exp Med       Date:  2014-11-15

3.  Vertebral artery and osseous anomalies characteristic at the craniocervical junction diagnosed by CT and 3D CT angiography in normal Czech population: analysis of 511 consecutive patients.

Authors:  P Vaněk; Ondřej Bradáč; P de Lacy; R Konopková; J Lacman; V Beneš
Journal:  Neurosurg Rev       Date:  2016-09-13       Impact factor: 3.042

Review 4.  Recent Advances in Cerebellar Ischemic Stroke Syndromes Causing Vertigo and Hearing Loss.

Authors:  Hyun-Ah Kim; Hyon-Ah Yi; Hyung Lee
Journal:  Cerebellum       Date:  2016-12       Impact factor: 3.847

5.  Cerebellar infarction after head injury.

Authors:  Amit Agrawal; Anand Kakani
Journal:  J Emerg Trauma Shock       Date:  2010-04

6.  Massive cerebellar infarct complicated by hydrocephalus.

Authors:  R M Antonello; M Pasqua; A Bosco; P Torre
Journal:  Ital J Neurol Sci       Date:  1992-11

7.  Treatment of cerebellar masses.

Authors:  Mahmut Edip Gurol; Erik K St Louis
Journal:  Curr Treat Options Neurol       Date:  2008-03       Impact factor: 3.598

Review 8.  Vertebrobasilar infarcts in infancy: a case report and review of the literature.

Authors:  P Luchini; F Guida; F di Paola; A Bocca; G Bisetto; P Longatti
Journal:  Childs Nerv Syst       Date:  1992-10       Impact factor: 1.475

9.  Focal Ischaemic Infarcts Expand Faster in Cerebellar Cortex than Cerebral Cortex in a Mouse Photothrombotic Stroke Model.

Authors:  Nagarajesh Gorlamandala; Jasneet Parmar; Amanda J Craig; John M Power; Andrew J Moorhouse; Arun V Krishnan; Gary D Housley
Journal:  Transl Stroke Res       Date:  2018-02-17       Impact factor: 6.829

10.  Neuro-otological aspects of cerebellar stroke syndrome.

Authors:  Hyung Lee
Journal:  J Clin Neurol       Date:  2009-06-30       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.